N4 Pharma has been featured in the latest issue of BioPharm International.
Nigel Theobald, CEO of N4 Pharma, has spoken to Dr. Kevin Robinson at Manufacturing Chemist magazine about how the company has developed Nuvec® and the impact it could have for vaccines and cancer treatments.
N4 Pharma (LON:N4P) is a consumer-driven pharmaceutical company developing reformulations of a number of key drugs.
Investors are spoiled for choice when it comes to small cap stocks with exciting events. As a taster for what’s to come in 2018, we’ve scoured the markets to look for some of the most interesting activities. Read on to discover 19 stocks either expecting big news in the [...]